Chemed Inc (CHE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 2,431,287 | 2,264,417 | 2,134,963 | 2,139,261 | 2,079,583 |
| Cost of Goods | 1,576,939 | 1,465,602 | 1,369,877 | 1,369,458 | 1,378,197 |
| Gross Profit | 854,348 | 798,815 | 765,086 | 769,803 | 701,386 |
| Operating Expenses | 488,794 | 458,848 | 422,467 | 427,223 | 311,903 |
| Operating Income | 366,493 | 340,569 | 343,496 | 343,038 | 389,680 |
| Interest Expense | 1,780 | 3,108 | 4,584 | 1,868 | 2,355 |
| Other Income | 34,752 | 12,906 | -9,233 | 9,144 | 8,665 |
| Pre-tax Income | 399,465 | 350,367 | 329,679 | 350,314 | 395,990 |
| Income Tax | 97,466 | 77,858 | 80,055 | 81,764 | 76,524 |
| Net Income Continuous | 301,999 | 272,509 | 249,624 | 268,550 | 319,466 |
| Net Income | $301,999 | $272,509 | $249,624 | $268,550 | $319,466 |
| EPS Basic Total Ops | 20.10 | 18.11 | 16.72 | 17.14 | 20.02 |
| EPS Basic Continuous Ops | 20.10 | 18.11 | 16.72 | 17.14 | 20.02 |
| EPS Diluted Total Ops | 19.89 | 17.93 | 16.53 | 16.85 | 19.48 |
| EPS Diluted Continuous Ops | 19.89 | 17.93 | 16.53 | 16.85 | 19.48 |
| EPS Diluted Before Non-Recurring Items | 21.31 | 20.30 | 19.75 | 19.33 | 18.08 |
| EBITDA(a) | $429,863 | $402,014 | $403,010 | $402,395 | $446,569 |